Great Novel Therapeutics Biotech & Medicals Corporation (7427)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
72. 80
+4.2
+6.1224%
NT$
- Market Cap
- P/E Ratio
30% Div Yield
986,133 Volume
- Eps
NT$ 68.6
Previous Close Want to track 7427 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Great Novel Therapeutics Biotech & Medicals Corporation (7427) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.98B
Trailing P/E (ttm) -31.58
Forward P/E -
PEG ratio -3.08
Price/Sales (ttm) 2,492.86
Price/Book (mrq) 6.27
Enterprise Value/Revenue 2,474.61
Enterprise Value/EBITDA -31.95
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 621.52K
Average volume (90 days) 816.49K
Price summary
52-Week low 29.25
52-Week high 82.8
Beta -
50-Day moving average 56.51
200-Day moving average 41.41
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 26 Feb 2026
Ex-Dividend Date 26 Feb 2026
Last split factor 11:10
Last split Date 31 Jan 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -80.89%
Operating margin -82.61%
Operational effectiveness
Return on assets -0.19%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 24.12%
Book value per share (mrq) 11.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
